loadpatents
name:-0.044090032577515
name:-0.035568952560425
name:-0.0053331851959229
PIO; Barbara Patent Filings

PIO; Barbara

Patent Applications and Registrations

Patent applications and USPTO patent grants for PIO; Barbara.The latest application filed is for "1-pyrazolyl, 5-, 6- disubstituted indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof".

Company Profile
3.38.43
  • PIO; Barbara - Kenilworth NJ US
  • Pio; Barbara - West Orange NJ
  • PIO; Barbara - Rahway NJ US
  • Pio; Barbara - Hillsborough NJ US
  • Pio; Barbara - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
1-pyrazolyl, 5-, 6- Disubstituted Indazole Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof
App 20220259188 - Zhou; Hua ;   et al.
2022-08-18
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
Grant 11,174,248 - Acton , et al. November 16, 2
2021-11-16
Antidiabetic heterocyclic compounds
Grant 11,072,602 - Miller , et al. July 27, 2
2021-07-27
Indazolyl-spiro[2.3]hexane-carbonitrile Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof
App 20210188818 - Acton; John ;   et al.
2021-06-24
Antidiabetic spirochroman compounds
Grant 10,968,232 - Miller , et al. April 6, 2
2021-04-06
Antidiabetic bicyclic compounds
Grant 10,662,171 - Chobanian , et al.
2020-05-26
Antidiabetic Heterocyclic Compounds
App 20190367495 - Miller; Michael ;   et al.
2019-12-05
Antidiabetic Spirochroman Compounds
App 20190337961 - Miller; Michael ;   et al.
2019-11-07
Antidiabetic compounds
Grant 10,059,667 - Chobanian , et al. August 28, 2
2018-08-28
Inhibitors of the renal outer medullary potassim channel
Grant 10,000,484 - Chobanian , et al. June 19, 2
2018-06-19
Antidiabetic bicyclic compounds
Grant 9,957,219 - Bara , et al. May 1, 2
2018-05-01
Antidiabetic bicyclic compounds
Grant 9,840,512 - Brockunier , et al. December 12, 2
2017-12-12
Antidiabetic substituted heteroaryl compounds
Grant 9,834,563 - Hagmann , et al. December 5, 2
2017-12-05
Inhibitors Of The Renal Outer Medullary Potassium Channel
App 20170275302 - Pasternak; Alexander ;   et al.
2017-09-28
Inhibitors of the renal outer medullary potassium channel
Grant 9,751,881 - Tang , et al. September 5, 2
2017-09-05
Antidiabetic Bicyclic Compounds
App 20170217920 - Chobanian; Harry ;   et al.
2017-08-03
Antidiabetic Substituted Heteroaryl Compounds
App 20170166578 - Hagmann; William K. ;   et al.
2017-06-15
Inhibitors of the renal outer medullary potassium channel
Grant 9,604,998 - Pasternak , et al. March 28, 2
2017-03-28
Inhibitors of the renal outer medullary potassium channel
Grant 9,573,961 - Pasternak , et al. February 21, 2
2017-02-21
Inhibitors of the renal outer medullary potassium channel
Grant 9,527,830 - Walsh , et al. December 27, 2
2016-12-27
Antidiabetic Compounds
App 20160332968 - Chobanian; Harry ;   et al.
2016-11-17
Inhibitors Of The Renal Outer Medullary Potassim Channel
App 20160304515 - Chobanian; Harry ;   et al.
2016-10-20
Thrombin inhibitors
Grant 9,469,608 - Chobanian , et al. October 18, 2
2016-10-18
Antidiabetic Bicyclic Compounds
App 20160280626 - Bara; Thomas ;   et al.
2016-09-29
Inhibitors of the Renal Outer Medullary Potassium Channel
App 20160207922 - Tang; Haifeng ;   et al.
2016-07-21
Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists
Grant 9,340,530 - Mandal , et al. May 17, 2
2016-05-17
Antidiabetic Bicyclic Compounds
App 20160002255 - Brockunier; Linda L. ;   et al.
2016-01-07
Inhibitors Of The Renal Outer Medullary Potassium Channel
App 20160002259 - Pasternak; Alexander ;   et al.
2016-01-07
Inhibitors of the renal outer medullary potassium channel
Grant 9,206,199 - Pio , et al. December 8, 2
2015-12-08
Inhibitors of the Renal Outer Medullary Potassium Channel
App 20150329557 - Pasternak; Alexander ;   et al.
2015-11-19
Thrombin Inhibitors
App 20150315141 - Chobanian; Harry ;   et al.
2015-11-05
Inhibitors of the Renal Outer Medullary Potassium channel
Grant 9,139,585 - Walsh , et al. September 22, 2
2015-09-22
Inhibitors of the renal outer medullary potassium channel
Grant 9,073,882 - Tang , et al. July 7, 2
2015-07-07
Inhibitors of the renal outer medullary potassium channel
Grant 9,062,070 - Pasternak , et al. June 23, 2
2015-06-23
Inhibitors of the renal outer medullary potassium channel
Grant 9,056,859 - Pasternak , et al. June 16, 2
2015-06-16
Inhibitors of the renal outer medullary potassium channel
Grant 8,999,991 - Tang , et al. April 7, 2
2015-04-07
Inhibitors of the renal outer medullary potassium channel
Grant 8,999,990 - Tang , et al. April 7, 2
2015-04-07
Preparation And Use Of Bicyclic Himbacine Derivatives As Par-1 Receptor Antagonists
App 20150025046 - Mandal; Mihir ;   et al.
2015-01-22
Inhibitors Of The Renal Outer Medullary Potassium Channel
App 20140336177 - Pio; Barbara ;   et al.
2014-11-13
Inhibitors Of The Renal Outer Medullary Potassium Channel
App 20140309213 - Walsh; Shawn P. ;   et al.
2014-10-16
Inhibitors of the Renal Outer Medullary Potassium Channel
App 20140296225 - Tang; Haifeng ;   et al.
2014-10-02
Inhibitors of the Renal Outer Medullary Potassium Channel
App 20140288088 - Tang; Haifeng ;   et al.
2014-09-25
Inhibitors of the Renal Outer Medullary Potassium Channel
App 20140206618 - Pasternak; Alexander ;   et al.
2014-07-24
Inhibitors Of The Renal Outer Medullary Potassium Channel
App 20130225561 - Tang; Haifeng ;   et al.
2013-08-29
Inhibitors of the Renal Outer Medullary Potassium Channel
App 20130217680 - Pasternak; Alexander ;   et al.
2013-08-22
Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
Grant 8,236,819 - Lagu , et al. August 7, 2
2012-08-07
Bicyclic androgen and progesterone receptor modulator compounds and methods
App 20110112084 - Zhi; Lin ;   et al.
2011-05-12
Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
Grant 7,723,326 - Lagu , et al. May 25, 2
2010-05-25
Dihydro-[1h]-quinolin-2-one Derivatives As Rxr Agonists For The Treatment Of Dyslipidemia, Hypercholesterolemia And Diabetes
App 20100105728 - Lagu; Bharat ;   et al.
2010-04-29
Bicyclic androgen and progesterone receptor modulator compounds and methods
App 20100069379 - Zhi; Lin ;   et al.
2010-03-18
Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
Grant 7,638,533 - Lagu , et al. December 29, 2
2009-12-29
Androgen receptor modulator compounds and methods
App 20070167445 - Higuchi; Robert I. ;   et al.
2007-07-19
Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
App 20070078129 - Lagu; Bharat ;   et al.
2007-04-05
Dihydro-[1h]-quinolin-2-one Derivatives As Rxr Agonists For The Treatment Of Dyslipidemia, Hypercholesterolemia And Diabetes
App 20070078160 - Lagu; Bharat ;   et al.
2007-04-05
Bicyclic androgen and progesterone receptor modulator compounds and methods
Grant 6,964,973 - Zhi , et al. November 15, 2
2005-11-15
Heterocyclic compounds
App 20050085487 - Carruthers, Nicholas I. ;   et al.
2005-04-21
Heterocyclic compounds
Grant 6,803,362 - Carruthers , et al. October 12, 2
2004-10-12
Heterocyclic compounds
App 20030207893 - Carruthers, Nicholas I. ;   et al.
2003-11-06
Androgen receptor modulator compounds and methods
App 20030186970 - Higuchi, Robert ;   et al.
2003-10-02
Bicyclic androgen and progesterone receptor modulator compounds and methods
App 20030130505 - Zhi, Lin ;   et al.
2003-07-10
Androgen receptor modulator compounds and methods
Grant 6,462,038 - Higuchi , et al. October 8, 2
2002-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed